| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.2 | 7e-07 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-05 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.17 | 7e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.22 | 0.0001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0001 |